Global Biologics

Global Biologics Market Research Report: Forecast (2021-2026)

By Therapeutic Application (Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Metabolic disorders, Inflammatory Bowel Diseases, Respiratory Disorders, Neurological Disorders, Cardiovascular Read more

  • Healthcare
  • Jul 2021
  • 197
  • HC55023

Market Overview

Biologics are drugs derived from living organisms or comprised of components of a living organism. It is available in the form of genetically engineered proteins. These drugs help in the treatment of chronic diseases, including cancer, neurology, and cardiovascular disorders.

According to MarkNtel Advisors’ research report, “Global Biologics Market Analysis, 2021,” the market is likely to grow at a CAGR of around 9% during 2021-26. The growth of the Biologics market is associated with several factors, such as the surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients. Other factors driving the demand for biologics in the market include monoclonal antibodies for disease treatment and innovation & advancement in the healthcare & biotechnology sectors. Moreover, regulatory approval from the governments in different countries is also contributing to the growth of the Biologics market. 

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR (2021-2026) 9%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy
Asia-Pacific: China, India, Japan, South Korea, Australia 
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc, Bristol-Myers Squibb, Novartis, Pfizer, Sanofi
Unit Denominations USD Million/Billion

 

COVID-19 Pandemic Positively Impacted the Market Growth

The impact of COVID-19 has been leading to numerous research initiatives in biologics to find a suitable cure. Due to the pandemic, the global investments in biologics increased due to continuous demand for producing small molecule drugs. Thus, with the increasing number of COVID-19 cases, the need for biologics increased significantly. All the postponed treatments and consultations resumed in the last few months of 2020, which has resulted in aiding the number of treatment procedures using biologics. Hence, the Global Biologics Market is very likely to witness a significant surge in its growth rate in the forthcoming timeframe.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Expert Verbatim- Interview Excerpts of 10 industry experts
  4. Impact of COVID-19 on Global Biologics Market
  5. Global Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic Application
        1. Oncology
        2. Infectious Disease
        3. Autoimmune Disease
        4. Diabetes
        5. Metabolic disorders
        6. Inflammatory Bowel Diseases
        7. Respiratory Disorders
        8. Neurological Disorders
        9. Cardiovascular Disorder
        10. Musculoskeletal Disorders
        11. Ophthalmic Disorders
        12. Others
      2. By Distribution channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      3. By Manufacturing
        1. Outsource
        2. In-house
      4. By Product/Drug Class
        1. Recombinant therapeutic Products
          1. Monoclonal Antibodies
          2. Hormones
          3. Cytokines
          4. Enzymes
        2. Blood and Blood Components
        3. Cellular and Gene Therapy
        4. Vaccines
        5. Oligonucleotides
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      6. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  6. North America Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. US
        2. Canada
        3. Mexico
    3. US Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4.  Canada Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    5. Mexico Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  7. South America Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4. Argentina Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  8. Europe Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4. Germany Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    5. France Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    6. Italy Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    7. Spain Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  9. Asia-Pacific Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
  10. Market Share & Analysis
    1. By Therapeutic application
    2. By Distribution Channel
    3. By Manufacturing
    4. By Product/Drug Class
    5. By Country
      1. China
      2. India
      3. Japan
      4. Australia
      5. South Korea
      6. Others
  11. China Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  12. India Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  13. Japan Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  14. Australia Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  15. South Korea Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  16. Middle East and Africa Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
  17. UAE Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  18. Saudi Arabia Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  19. Global Biologics Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  20. Global Biologics Regulations, Product Standards
  21. Global Biologics Intellectual Property Rights Analysis
  22. Global Biologics Hotspots & Opportunities
  23. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
    2. Company Profiles
      1. Abbive Inc.
      2. Amgen Inc.
      3. F. Hoffman La Roche
      4. Samsung Electronics
      5. Merck & Co.
      6. AstraZenca Plc.
      7. Bristol-Myers Squibb
      8. Novartis
      9. Pfizer
      10. Sanofi
  24. Disclaimer
Global Biologics Market Segmentation
*This field is required